RCG
TIL icon

Rock Creek Group’s Instil Bio TIL Stock Holding History

Rock Creek Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,740
Closed -$404K – 216
2021
Q4 		$404K Buy
+1,740
New +$672K 0.06% 103

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rock Creek Group's TIL Position: Q1 2022 in Review

Rock Creek Group sold out of Instil Bio (TIL) in Q1 2022, closing a stake of 1,740 shares — an estimated $404K sold.

Rock Creek Group first reported a position in TIL in Q4 2021 and held it in 1 quarter. The position peaked at $404K in Q4 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q1 2022.

  • Rock Creek Group reported no remaining Instil Bio position as of Q1 2022 after selling out during the quarter.
  • Rock Creek Group sold 1,740 Instil Bio shares in Q1 2022, an estimated $404K.
  • Rock Creek Group first reported a position in Instil Bio in Q4 2021 and held it in 1 quarter.
  • Rock Creek Group's Instil Bio position peaked at $404K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q1 2022.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.